YaoGeJu

Company directoryChina company filings

Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.

As of 18 November 2026, for the company name Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd. as recorded, the chemical-drug catalogue lists 8 active records with this name as holder; 15 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

16 acceptance records as first applicant, grouped into 10 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Ambroxol Hydrochloride Injection 1 records · Latest accepted 2025/12/12

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2504262Generic2025/12/12Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
Lidocaine Hydrochloride Injection 1 records · Latest accepted 2025/03/20

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2550150Supplement2025/03/20Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
Chlorphenamine Maleate Injection 2 records · Latest accepted 2025/03/01

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2550130Supplement2025/03/01Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
CYHB2550129Supplement2025/03/01Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
Betamethasone Sodium Phosphate Injection 1 records · Latest accepted 2025/02/07

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500612Generic2025/02/07Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
Furosemide Injection 1 records · Latest accepted 2025/01/23

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2550072Supplement2025/01/23Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
Atropine Sulfate Injection 2 records · Latest accepted 2025/01/07

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2550023Supplement2025/01/07Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
CYHB2550022Supplement2025/01/07Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
Piracetam Injection 2 records · Latest accepted 2025/01/03

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2550005Supplement2025/01/03Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
CYHB2550004Supplement2025/01/03Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
盐酸消旋山莨菪碱注射液 · No verified English name 3 records · Latest accepted 2024/01/03

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2400003Supplement2024/01/03Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
CYHB2400002Supplement2024/01/03Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
CYHB2400001Supplement2024/01/03Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
Magnesium Sulfate Injection 1 records · Latest accepted 2023/12/28

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2302787Supplement2023/12/28Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
Aminophylline Injection 2 records · Latest accepted 2023/09/08

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2302030Supplement2023/09/08Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
CYHB2302029Supplement2023/09/08Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗

Changes in the last 90 days

0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

  1. No matching records were found in the currently loaded source data; coverage dates are listed below.

Under review

1 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Ambroxol Hydrochloride Injection CYHS2504262Generic2025/12/12Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗

Catalogue holder records

8 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Furosemide InjectionShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.国药准字H200451642026/03/09Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Lidocaine Hydrochloride InjectionShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.国药准字H410230582026/01/28Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Chlorphenamine Maleate InjectionShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.国药准字H200451612025/12/22Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Chlorphenamine Maleate InjectionShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.国药准字H410212902025/12/22Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Piracetam InjectionShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.国药准字H410246862025/12/05Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Piracetam InjectionShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.国药准字H410246852025/12/05Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Atropine Sulfate InjectionShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.国药准字H410236752025/12/03Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Atropine Sulfate InjectionShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.国药准字H410236762025/12/03Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

15 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
吡拉西坦 · No verified English nameShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Y20260000835I2026/10/13CDE ↗
草酸艾司西酞普兰 · No verified English nameShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Y20260000777I2026/09/10CDE ↗
碳酸氢钠 · No verified English nameShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Y20260000644I2026/08/17CDE ↗
盐酸利多卡因 · No verified English nameShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Y20250001401I2025/12/25CDE ↗
克立硼罗 · No verified English nameShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Y20250001097I2025/10/16CDE ↗
非布司他 · No verified English nameShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Y20240001487A2026/07/23CDE ↗
塞来昔布 · No verified English nameShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Y20240001315A2026/06/17CDE ↗
他达拉非 · No verified English nameShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Y20220001339A2026/07/07CDE ↗
桂利嗪 · No verified English nameShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Y20180001797A2024/03/13CDE ↗
双氯芬酸钾 · No verified English nameShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Y20180001783A2024/03/13CDE ↗
氢氯噻嗪 · No verified English nameShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Y20190007157A2023/03/24CDE ↗
尼群地平 · No verified English nameShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Y20190006757A—CDE ↗
盐酸普罗帕酮 · No verified English nameShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Y20190006755A—CDE ↗
红霉素 · No verified English nameShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Y20190006620A—CDE ↗
双氯芬酸钠 · No verified English nameShanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.Y20190006619A2026/08/17CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

6 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Magnesium Sulfate Injection CYHB2600787Supplement2026/04/22Hainan Quan Ying Pharma Co., Ltd. romanized; Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
Magnesium Sulfate Injection CYHS2302618Generic2023/09/28Hainan Quan Ying Pharma Co., Ltd. romanized; Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
尼可刹米注射液 · No verified English name CYHB2300195Supplement2023/02/01Hui Yu Yuan He (Hainan) Pharma Co., Ltd. romanized; Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
盐酸消旋山莨菪碱注射液 · No verified English name CYHB2202322Supplement2022/12/29Hui Yu Yuan He (Hainan) Pharma Co., Ltd. romanized; Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
盐酸消旋山莨菪碱注射液 · No verified English name CYHB2202321Supplement2022/12/29Hui Yu Yuan He (Hainan) Pharma Co., Ltd. romanized; Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗
盐酸消旋山莨菪碱注射液 · No verified English name CYHB2202320Supplement2022/12/29Hui Yu Yuan He (Hainan) Pharma Co., Ltd. romanized; Shanghai Jindi Jiuzhou Pharmaceutical (Anyang) Co.,Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.